Black Rock Inc. Cerevel Therapeutics Holdings, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Cerevel Therapeutics Holdings, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,560,931 shares of CERE stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,560,931

Previous 5,448,620 34.65%

Holding current value

Previous $230 Million 36.78%

% of portfolio

0.0%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$38.96 - $42.75 $73.5 Million - $80.7 Million	-1,887,689 Reduced 34.65%	3,560,931 $146 Million
Q1 2024 May 10, 2024	SELL	$40.88 - $43.27 $23.7 Million - $25 Million	-578,905 Reduced 9.6%	5,448,620 $230 Million
Q4 2023 Feb 13, 2024	BUY	$20.27 - $42.44 $21 Million - $44 Million	1,036,499 Added 20.77%	6,027,525 $256 Million
Q3 2023 Nov 13, 2023	BUY	$20.26 - $31.91 $3.21 Million - $5.05 Million	158,319 Added 3.28%	4,991,026 $109 Million
Q2 2023 Aug 11, 2023	BUY	$23.9 - $35.38 $8.31 Million - $12.3 Million	347,766 Added 7.75%	4,832,707 $154 Million
Q1 2023 May 12, 2023	BUY	$22.82 - $35.32 $61,111 - $94,586	2,678 Added 0.06%	4,484,941 $109 Million
Q4 2022 Feb 13, 2023	BUY	$25.35 - $31.96 $7.45 Million - $9.39 Million	293,892 Added 7.02%	4,482,263 $141 Million
Q3 2022 Nov 14, 2022	BUY	$25.5 - $41.42 $1.43 Million - $2.32 Million	56,084 Added 1.36%	4,188,371 $118 Million
Q2 2022 Aug 12, 2022	BUY	$20.62 - $37.15 $15.3 Million - $27.5 Million	740,872 Added 21.85%	4,132,287 $109 Million
Q1 2022 May 12, 2022	SELL	$23.5 - $35.38 $2.19 Million - $3.3 Million	-93,242 Reduced 2.68%	3,391,415 $119 Million
Q4 2021 Feb 10, 2022	BUY	$29.21 - $44.64 $3.55 Million - $5.42 Million	121,379 Added 3.61%	3,484,657 $113 Million
Q3 2021 Nov 09, 2021	BUY	$21.26 - $38.85 $15.1 Million - $27.6 Million	710,720 Added 26.79%	3,363,278 $99.2 Million
Q2 2021 Aug 11, 2021	BUY	$12.56 - $29.69 $33.3 Million - $78.8 Million	2,652,558 New	2,652,558 $68 Million

Others Institutions Holding CERE

# of Institutions

Shares Held

5.01M

Call Options Held

3.3K

Put Options Held

View Full List

About Cerevel Therapeutics Holdings, Inc.

Ticker CERE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 155,752,000
Description
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...

More about CERE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account